Precirix begins subject dosing in Phase I/II cancer therapy trial
The trial will analyse CAM-H2’s safety, tumour uptake, retention, and antitumour activity in HER2-positive cancer patients.
Belgium
Latest in
Belgium
ExeVir enrols first subject in Phase Ib/II trial of Covid antiviral therapy
The Phase Ib part will have up to 27 participants to assess three different doses of XVR011 given intravenously.
ExeVir doses first participants in Phase I Covid-19 antibody trial
The trial will assess the safety and pharmacokinetics of intravenous doses of XVR011 in healthy subjects.
Inotrem to extend Covid-19 therapy trial to France and Belgium
Inotrem will get funds worth $53m (€45m) from the French Government to extend the nangibotide trial in Covid-19 patients.
InteRNA Technologies begins dosing in solid tumour drug trial
InteRNA Technologies has dosed the first patient in the first cohort of its first-in-human Phase I study of its lead…
Biophytis starts Phase II/III Covid-19 trial of Sarconeos in Belgium
Biotechnology firm Biophytis has started enrolment and dosing of patients in a Phase II/III clinical trial to assess Sarconeos (BIO101)…
Biophytis and SGS partner to test Sarconeos in Covid-19 patients
French biotech firm Biophytis will assess its Sarconeos (BIO101) drug as a treatment for respiratory failure caused by Covid-19 after…
UCB reports positive data from BE READY trial of bimekizumab
UCB has reported positive results from the Phase III BE READY clinical trial of its investigational drug bimekizumab for the…